ArticleOncotarget2016

Integrated experimental and simulation study of the response to sequential treatment with erlotinib and gemcitabine in pancreatic cancer.

Paolo Ubezio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.